1. The Indian government encourages imitation, and even the United States imports from India.
The prosperity of generic drug industry has brought India the honorary title of "world pharmacy", and even the United States has to bow to India. At present, 40% generic drugs in the United States are imported from India. For American consumers, the price of Indian generic drugs is one tenth of that of patented drugs, but the effect is similar and there is no way to refuse.
Many people may not know that the history of generic drugs in India has been nearly 80 years. It can be said that the imitation experience is rich, and this credit belongs to the Indian government. For drug patents, the Indian government not only does not protect them, but also enforces licenses, which means that Indian companies can imitate patented drugs of multinational pharmaceutical companies under legal conditions.
2, Indian morality kidnapped American pharmaceutical companies, the United States: not to be taunted!
Allowing blatant "infringement" is not the original intention of the Indian government. The reason given is that most of these drugs are life-saving drugs. Is it necessary to let the poor die because the medicine is too expensive to buy? Although the world's major pharmaceutical companies do not want to buy the Indian government's account, European and American pharmaceutical companies are forced by moral pressure and dare not easily file a lawsuit against generic drugs. In addition, India had not yet joined the World Trade Organization and was not bound by international patent law.
Under the pressure of economic liberalization and reform, India joined the World Trade Organization (WTO). However, India's generic drug industry has formed a large-scale and mature development system. It is worth mentioning that the WTO gave India 10 a transition period to "protect pharmaceutical products", which accelerated the entry of Indian generic drugs into the international market, thus establishing a global competitive advantage.
3. Actively protect patents, and American pharmaceutical companies rushed to China.
In contrast, the degree of internationalization of China's pharmaceutical industry is obviously lower than that of India, and domestic pharmaceutical companies are not multinational companies. In fact, on the one hand, China started late, and on the other hand, the pharmaceutical giant suffered from the Indian "loss" and has registered a patent in China. As a big country in the world, China has the obligation to protect intellectual property rights and can only copy some medicines that have passed the patent protection period.